We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.78%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$377B
AUM Growth
+$49.7B
Cap. Flow
+$31.3B
Cap. Flow %
8.3%
Top 10 Hldgs %
41.14%
Holding
5,593
New
785
Increased
2,954
Reduced
1,009
Closed
322

Sector Composition

Rank Sector Weight
1 Technology 19.52%
2 Financials 7.13%
3 Consumer Discretionary 6.46%
4 Healthcare 5.43%
5 Communication Services 5.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMS icon
5051
Fresenius Medical Care
FMS
$13.4B
$21 ﹤0.01%
1
LSTA icon
5052
Lisata Therapeutics
LSTA
$9.93M
$21 ﹤0.01%
7
+3
+75% +$9
NEUE
5053
DELISTED
NeueHealth
NEUE
$21 ﹤0.01%
+4
New +$21
PDYNW icon
5054
Palladyne AI Corp Warrants
PDYNW
$240K
$19 ﹤0.01%
500
EVA
5055
DELISTED
Enviva Inc.
EVA
$16 ﹤0.01%
40
LANV.WS
5056
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$15 ﹤0.01%
500
CGC
5057
Canopy Growth
CGC
$376M
$14 ﹤0.01%
3
CBIO
5058
Crescent Biopharma
CBIO
$546M
$13 ﹤0.01%
1
ZSQR
5059
Z Squared Inc
ZSQR
$279M
$12 ﹤0.01%
3
HEPA
5060
DELISTED
Hepion Pharmaceuticals
HEPA
0
XMAX
5061
XMAX Inc
XMAX
$530M
$11 ﹤0.01%
7
BYSI icon
5062
BeyondSpring
BYSI
$47.3M
$9 ﹤0.01%
4
TLPH icon
5063
Talphera
TLPH
$68M
$9 ﹤0.01%
+11
New +$10
MRNO
5064
Murano Global Investments
MRNO
$16M
$9 ﹤0.01%
+1
New +$8
NERV icon
5065
Minerva Neurosciences
NERV
$191M
$8 ﹤0.01%
+3
New +$9
CEI
5066
DELISTED
Camber Energy, Inc
CEI
$8 ﹤0.01%
360
SENS icon
5067
Senseonics Holdings Inc
SENS
$254M
$7 ﹤0.01%
1
-20
-95% -$161
FBRX icon
5068
Forte Biosciences
FBRX
$1.57B
$6 ﹤0.01%
+1
New +$10
CRVS icon
5069
Corvus Pharmaceuticals
CRVS
$1.1B
$5 ﹤0.01%
1
NVVE
5070
DELISTED
Nuvve Holding Corp
NVVE
0
JWSM.WS
5071
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$5 ﹤0.01%
250
OTLY
5072
Oatly Group
OTLY
$476M
0
SWVLW icon
5073
Swvl Holdings Corp Warrant
SWVLW
$143K
$4 ﹤0.01%
238
VATE icon
5074
INNOVATE Corp
VATE
$106M
$4 ﹤0.01%
1
-2,261
-100% -$11.2K
GRMLW
5075
Greenland Mines Ltd Warrant
GRMLW
$4 ﹤0.01%
100

Similar funds

Barclays's Q3 2024 Portfolio in Review

As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.

  • Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
  • Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
  • Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
  • Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
  • Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
  • Barclays opened 785 new positions and closed 322 in Q3 2024.
  • Barclays's portfolio value rose 15% quarter-over-quarter to $377B.

Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.